EMA — authorised 9 June 2000
- Marketing authorisation holder: sanofi-aventis Deutschland GmbH
- Status: approved
EMA authorised Lantus on 9 June 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 9 June 2000.
sanofi-aventis Deutschland GmbH holds the EU marketing authorisation.